These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35726770)

  • 41. Salvage surgery after head and neck squamous cell carcinoma treated with bioradiotherapy.
    Rovira A; Tornero J; Oliva M; Taberna M; Montal R; Nogues J; Farre A; Lares H; Navarro V; Mari A; Vinals JM; Lozano A; Mesia R; Manos M
    Head Neck; 2017 Jan; 39(1):116-121. PubMed ID: 27459296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
    Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL
    Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypothyroidism in patients treated with radiotherapy for head and neck carcinoma: standardised long-term follow-up study.
    Alba JR; Basterra J; Ferrer JC; Santonja F; Zapater E
    J Laryngol Otol; 2016 May; 130(5):478-81. PubMed ID: 26975210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.
    Gupta T; Agarwal J; Jain S; Phurailatpam R; Kannan S; Ghosh-Laskar S; Murthy V; Budrukkar A; Dinshaw K; Prabhash K; Chaturvedi P; D'Cruz A
    Radiother Oncol; 2012 Sep; 104(3):343-8. PubMed ID: 22853852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgery or Radiotherapy of the Primary Tumor in T1-2 Head and Neck Squamous Cell Carcinoma with Resectable N3 Nodes: A Multicenter GETTEC Study.
    Carsuzaa F; Thariat J; Gorphe P; Righini C; Cosmidis A; Thureau S; Roge M; De Mones E; Servagi-Vernat S; Tonnerre D; Morinière S; Dugas A; Malard O; Pasquier F; Vergez S; Salleron J; Dufour X
    Ann Surg Oncol; 2019 Oct; 26(11):3673-3680. PubMed ID: 31264120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Timely delivery of PORT for head and neck squamous cell carcinoma in a county hospital.
    Rosas Herrera AM; Haskins AD; Hanania AN; Jhaveri PM; Chapman CH; Huang Q; Hernandez DJ
    Laryngoscope Investig Otolaryngol; 2024 Feb; 9(1):e1211. PubMed ID: 38362185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer.
    Graboyes EM; Sterba KR; Li H; Warren GW; Alberg AJ; Calhoun EA; Nussenbaum B; McCay J; Marsh CH; Osazuwa-Peters N; Neskey DM; Kaczmar JM; Sharma AK; Harper J; Day TA; Hughes-Halbert C
    JCO Oncol Pract; 2021 Oct; 17(10):e1512-e1523. PubMed ID: 33689399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    PLoS One; 2018; 13(7):e0200137. PubMed ID: 29979726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes for elderly patients 75 years and older treated with curative intent radiotherapy for mucosal squamous cell carcinomas of the head and neck.
    Horsley PJ; Perera L; Veness MJ; Stevens MJ; Eade TN; Back M; Brown C; Jayamanne DT
    Head Neck; 2020 Jan; 42(1):25-32. PubMed ID: 31593357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analyses of clinicopathologic factors affecting neck control after postoperative radiation as adjuvant treatment for lymph node metastasis in head and neck squamous cell carcinoma].
    Di B; Li XM; Zhang JJ; Liu S; Song Q; Tao ZF; Fan C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):485-90. PubMed ID: 27480295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors Associated With the Choice of Radiation Therapy Treatment Facility in Head and Neck Cancer.
    Sullivan CB; Al-Qurayshi Z; Anderson CM; Seaman AT; Pagedar NA
    Laryngoscope; 2021 May; 131(5):1019-1025. PubMed ID: 32846018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stroke After Radiation Therapy for Head and Neck Cancer: What Is the Risk?
    Arthurs E; Hanna TP; Zaza K; Peng Y; Hall SF
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):589-96. PubMed ID: 27681754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis.
    Overgaard J
    Radiother Oncol; 2011 Jul; 100(1):22-32. PubMed ID: 21511351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of national holidays on postoperative radiotherapy of squamous cell carcinoma of the head and neck.
    Kim MS; Sheridan M; Rajaraman M; Hollenhorst H; Caissie A; Mahmoud-Ahmed A; Lamond N; Snow S; Corsten M; Mark Taylor S; Trites JRB; Rigby MH; Bullock M; Wilke D
    Clin Transl Radiat Oncol; 2023 Sep; 42():100668. PubMed ID: 37608964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy.
    Toppi J; Tham YS; Webb A; Henderson MA; Rischin D; Magarey MJR
    ANZ J Surg; 2020 Jul; 90(7-8):1391-1395. PubMed ID: 32627359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.